NeuroBo Pharmaceuticals, Inc.
Methods of reducing risk of cardiovascular disease
Last updated:
Abstract:
Methods of lowering the plasma LDL-C levels in a patient on a stable dose of statin where the patient has an LDL-C level above treatment goal. Methods of decreasing a patient's risk for developing coronary heart disease, having a recurrent cardiovascular event or reducing the severity of a secondary cardiovascular event, wherein the patient is on a stable dose of statin and the patient has an LDL-C level above treatment goal.
Status:
Grant
Type:
Utility
Filling date:
29 Jun 2018
Issue date:
14 Jul 2020